Teva Pharmaceutical Industries ADR (TEVA)

Mar 31, 2025, 1:00 PM EDT - 2 days ago

New Data Strengthens Teva's Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

Mar 27, 2025, 4:30 PM EDT - 6 days ago

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

Mar 27, 2025, 4:30 PM EDT - 6 days ago

Teva Releases Q1 2025 Aide Memoire

Mar 14, 2025, 6:08 PM EDT - 19 days ago

Drugmakers agree to participate in second round of price negotiations

ABBV AZN GSK MRK NVO

Mar 12, 2025, 12:15 PM EDT - 21 days ago

Teva Pharmaceutical Industries Limited (TEVA) Leerink's 2025 Global Healthcare Conference (Transcript)

Mar 11, 2025, 1:07 PM EDT - 22 days ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)

Mar 6, 2025, 12:27 PM EST - 27 days ago

Teva: Branded Momentum Clashes With Generic Declines And IRA Headwinds

Mar 3, 2025, 4:30 PM EST - 4 weeks ago

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

Feb 27, 2025, 8:00 AM EST - 4 weeks ago

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

Feb 25, 2025, 4:00 PM EST - 5 weeks ago

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

Feb 24, 2025, 10:48 AM EST - 5 weeks ago

Teva Pharmaceutical Industries Limited (TEVA) Duvakitug (Anti-TL1A) Phase 2 Investors Call to Discuss New Data Presented at ECCO Conference (Transcript)

Feb 22, 2025, 2:20 AM EST - 5 weeks ago

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn's Disease

Feb 21, 2025, 6:27 PM EST - 5 weeks ago

Final Trade: TEVA, JNJ, TJX, BABA

JNJ TJX BABA

Feb 21, 2025, 6:44 AM EST - 5 weeks ago

Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara

ALVO JNJ

Feb 18, 2025, 4:30 PM EST - 6 weeks ago

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)

Feb 18, 2025, 11:30 AM EST - 6 weeks ago

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea

ALVO

Feb 18, 2025, 6:00 AM EST - 6 weeks ago

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Feb 17, 2025, 4:42 AM EST - 6 weeks ago

Teva Pharm CEO calls for faster US generic drug approvals

Feb 11, 2025, 5:20 PM EST - 7 weeks ago

Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade

AXSM

Feb 10, 2025, 12:33 PM EST - 7 weeks ago

Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'

AXSM

Feb 10, 2025, 2:00 AM EST - 7 weeks ago

Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals

Jan 30, 2025, 1:35 PM EST - 2 months ago

Teva Pharmaceutical: 2025 Guidance Sinks The Stock, But Presents An Opportunity

Jan 29, 2025, 1:39 PM EST - 2 months ago

Crude Oil Down 1.5%; Teva Pharmaceutical Shares Plummet

Jan 29, 2025, 12:24 PM EST - 2 months ago

Teva Pharma CEO: Guidance based on the new Teva that grows every year

Jan 29, 2025, 12:02 PM EST - 2 months ago

Teva Pharmaceutical Industries Limited (TEVA) Q4 2024 Earnings Conference Call Transcript

Jan 29, 2025, 7:19 AM EST - 2 months ago

Teva Pharm Q4 tops estimates on strong sales of its own drugs

Jan 28, 2025, 1:33 PM EST - 2 months ago

Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data

Jan 27, 2025, 6:00 AM EST - 2 months ago

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

Jan 19, 2025, 4:54 PM EST - 2 months ago

Top 4 Immunology Stocks Poised For Growth In 2025

ABBV BMY SNY

Jan 13, 2025, 2:00 PM EST - 2 months ago

Teva Pharmaceutical Industries Limited (TEVA) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Jan 13, 2025, 1:03 PM EST - 2 months ago

Teva Pharmaceuticals CEO talks Trump and US healthcare

Jan 13, 2025, 10:35 AM EST - 2 months ago

Teva CEO on Drug Pricing, Generics, Supply Shortages

Jan 13, 2025, 1:00 AM EST - 2 months ago

Teva Announces Collaboration to Commercialize Formycon's Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

Jan 10, 2025, 8:30 AM EST - 2 months ago

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

Dec 27, 2024, 3:21 PM EST - 3 months ago

Duvakitug And Teva's Growth: A Game Changer In Pharma

Dec 23, 2024, 4:30 PM EST - 3 months ago

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 20, 2024, 4:30 PM EST - 3 months ago

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

Dec 18, 2024, 2:29 PM EST - 3 months ago

Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases

Dec 18, 2024, 4:32 AM EST - 3 months ago

TEVA stock soars 26%: What's going on with Teva Pharmaceuticals?

Dec 17, 2024, 4:50 PM EST - 3 months ago

Overlooked Stock: TEVA

Dec 17, 2024, 2:25 PM EST - 3 months ago

Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's

SNY

Dec 17, 2024, 11:51 AM EST - 3 months ago

Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment

SNY

Dec 17, 2024, 9:16 AM EST - 3 months ago

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?

SNY

Dec 17, 2024, 7:35 AM EST - 3 months ago

Teva, Sanofi say drug to treat IBD met primary targets

SNY

Dec 17, 2024, 7:30 AM EST - 3 months ago

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn's Disease

Dec 6, 2024, 8:00 AM EST - 4 months ago

Can Teva Return To All-Time Highs?

Dec 5, 2024, 6:39 PM EST - 4 months ago

Pharma firm Teva to divest its business venture in Japan

Dec 5, 2024, 6:00 PM EST - 4 months ago

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

Dec 5, 2024, 1:23 PM EST - 4 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference Call Transcript

Dec 4, 2024, 2:00 AM EST - 4 months ago

Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial